Bladder urothelial carcinoma
Conditions
Interventions
Gold Standard:Biopsy or postoperative pathological examination (histopathological diagnosis)
Index test:Index test: Liquid biopsy–based multi-omics tumor biomarker assays using blood and/or urine samples.
Sponsors
The First Affiliated Hospital of Wenzhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Participants age >=18 years with suspected urological malignancies who have not received prior treatment and meet any of the following criteria; 1.Patients with suspected urological tumors identified through examination to be at risk for urological malignancies (including but not limited to urothelial carcinoma, prostate cancer, renal cell carcinoma, etc.) who are willing to undergo biopsy or surgical treatment; 2.Patients diagnosed with benign urological diseases through standard diagnostic methods.
Exclusion criteria
Exclusion criteria: 1.Patients who are unwilling or unable to provide sufficient biological samples as required; 2.Patients identified as suspected or high-risk for malignancy through clinical examinations but who are unwilling to undergo biopsy or surgical treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;Accuracy;Specificity; | — |
Countries
China
Contacts
Public ContactHuang Hang
The First Affiliated Hospital of Wenzhou Medical University
Outcome results
None listed